Researchers from Amsterdam UMC, in collaboration with other hospitals, have successfully completed the first Phase III study of an in vivo CRISPR therapy. In this large-scale, double-blind trial, 80 ...
Researchers from Amsterdam UMC, in collaboration with other hospitals, have successfully completed the first Phase III study of an in vivo CRISPR therapy. In this large-scale, double-blind trial, 80 ...
Philadelphia and Gordonville, PA, August 12, 2025 – Researchers from Children’s Hospital of Philadelphia (CHOP) and the Clinic for Special Children found that complement factor I (CFI) deficiency, an ...
Marissa Russo is a former STAT intern supported by the AAAS Mass Media Science & Engineering Fellowship. In what experts are calling a “dream come true,” scientists used a recent biochemical discovery ...
Global biopharma company encourages education and awareness around a rare bleeding disorder. FORT LEE, N.J., Oct. 10, 2023 /PRNewswire/ -- Kedrion Biopharma, an international biopharmaceutical company ...
Given the heterogeneity and rarity of inborn errors of immunity (IEIs), management guidelines that deal with primary immunodeficiency as a whole are rare. The most recent general guideline, the ...
Hereditary angioedema (HAE) is diagnosed through blood tests that measure complement protein (C4) and complement inhibitor (C1-INH) levels. Low C4 levels strongly suggest HAE, especially during an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results